Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Stoneridge
SRI
$200M
| $6.45M | ﹤0.01% |
326,669
+29,087
| +10% | +$615K |
|
|
NTST
2227
NETSTREIT Corp
NTST
$2.09B
| $6.45M | ﹤0.01% |
281,447
+5,036
| +2% | +$117K |
|
2228
Universal Insurance Holdings
UVE
$1.24B
| $6.41M | ﹤0.01% |
376,791
+24,000
| +7% | +$363K |
|
|
SGMO
2229
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $6.37M | ﹤0.01% |
849,644
-89,690
| -10% | -$779K |
|
2230
Heron Therapeutics
HRTX
$96.3M
| $6.36M | ﹤0.01% |
696,257
-269
| -0% | -$2.75K |
|
|
BMTC
2231
DELISTED
Bryn Mawr Bank Corp
BMTC
| $6.35M | ﹤0.01% |
141,085
+1,802
| +1% | +$84.8K |
|
2232
KE Holdings
BEKE
$18.8B
| $6.35M | ﹤0.01% |
315,369
+10,210
| +3% | +$209K |
|
2233
Hertz
HTZ
$477M
| $6.33M | ﹤0.01% |
+253,160
| New | +$6.06M |
|
|
SHCR
2234
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $6.31M | ﹤0.01% |
1,405,311
+37,676
| +3% | +$242K |
|
2235
America's Car Mart
CRMT
$27.4M
| $6.29M | ﹤0.01% |
61,384
+5,983
| +11% | +$675K |
|
2236
Liberty Latin America Class A
LILA
$1.69B
| $6.28M | ﹤0.01% |
793,177
+14,810
| +2% | +$123K |
|
|
AY
2237
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $6.26M | ﹤0.01% |
175,156
+9,831
| +6% | +$369K |
|
2238
Sylvamo
SLVM
$1.53B
| $6.25M | ﹤0.01% |
+224,244
| New | +$6.53M |
|
|
ARR
2239
Armour Residential REIT
ARR
$2.34B
| $6.25M | ﹤0.01% |
127,459
+10,799
| +9% | +$559K |
|
2240
Ocugen
OCGN
$423M
| $6.24M | ﹤0.01% |
1,371,227
+20,107
| +1% | +$152K |
|
2241
Navitas Semiconductor
NVTS
$2.85B
| $6.24M | ﹤0.01% |
+366,750
| New | +$5.5M |
|
2242
Univest Financial
UVSP
$1.22B
| $6.21M | ﹤0.01% |
207,403
+2,804
| +1% | +$81.5K |
|
|
ENDP
2243
DELISTED
Endo International plc
ENDP
| $6.21M | ﹤0.01% |
1,650,147
+140,019
| +9% | +$678K |
|
2244
Orthofix Medical
OFIX
$500M
| $6.19M | ﹤0.01% |
199,201
+11,626
| +6% | +$389K |
|
2245
BioLife Solutions
BLFS
$1.55B
| $6.17M | ﹤0.01% |
165,644
-27,429
| -14% | -$1.18M |
|
2246
Bionano Genomics
BNGO
$13.1M
| $6.13M | ﹤0.01% |
3,415
+178
| +5% | +$476K |
|
2247
Nomad Foods
NOMD
$1.69B
| $6.12M | ﹤0.01% |
240,961
-11,982
| -5% | -$309K |
|
|
KREF
2248
KKR Real Estate Finance Trust
KREF
$456M
| $6.11M | ﹤0.01% |
293,139
+26,613
| +10% | +$573K |
|
|
UHT
2249
Universal Health Realty Income Trust
UHT
$599M
| $6.11M | ﹤0.01% |
102,669
+1,986
| +2% | +$116K |
|
2250
First Advantage
FA
$3.47B
| $6.1M | ﹤0.01% |
320,257
+132,005
| +70% | +$2.54M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.